Summary
The effects of 21 days of haloperidol treatment on central benzodiazepine (BZ) receptors in the cerebral cortex of rats and on peripheral-type BZ binding sites (PBS) in the cerebral cortex and heart of rats were studied. Neuroleptic treatment did not affect the maximal binding capacity or the affinity of the central BZ receptor to3H-flunitrazepam. Chronic haloperidol treatment resulted in a significant increase of 38% in PBS density in the cerebral cortex, with no alteration in PBS density in the heart. No alteration in PBS affinity for its ligand3H-PK 11195 was observed, either in the cerebral cortex or in the heart. The modulatory effect of chronic haloperidol administration on PBS density in the brain may be related to some of the neurobehavioral or hormonal effects of the drug.
Similar content being viewed by others
References
Anholt RRH, De Souza EB, Kuhar MJ, Snyder SH (1985) Depletion of peripheral-type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. Eur J Pharmacol 110: 41–46
Anholt RRH, Murphy KMM, Mack GE, Snyder SH (1984) Peripheral-type benzodiazepine receptors in the central nervous system: localization to olfactory nerves. J Neurosci 4: 593–603
Basile AS, Ostrowski NL, Skolnick P (1987) Aldosterone-reversible decrease in the density of renal peripheral benzodiazepine receptors in the rat after adrenalectomy. J Pharmacol Exp Ther 20: 1006–1013
Basile AS, Paul SM, Skolnick P (1985) Adrenalectomy reduces the density of “peripheral-type” binding sites for benzodiazepines in the rat kidney. Eur J Pharmacol 110: 149–150
Benavides J, Fage D, Carter C, Scatton B (1987) Peripheral-type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res 421: 167–172
Benavides J, Quarteronet D, Imbault F, Malgouris C, Uzan A, Renault C, Dubroeucq MC, Gueremy C, Le Fur G (1983) Labeling of “peripheral-type” benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J Neurochem 41: 1744–1750
Benavides J, Quarteronet D, Plouin P-F, Imbault F, Phan T, Uzan A, Renault C, Dubroeucq M-C, Gueremy C, Le Fur G (1984) Characterization of peripheral-type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195: studies in hypertensive patients. Biochem Pharmacol 33: 2467–2472
Deckert G, Marangos PJ (1986) Hormonal interactions with benzodiazepine binding sites in vitro. Life Sci 39: 675–683
Drugan RC, Basile AS, Crawley JN, Paul SM, Skolnick P (1986) Inescapable shock reduces [3H]Ro 5-4864 binding to “peripheral-type” benzodiazepine receptors in the rat. Pharmacol Biochem Behav 24: 1673–1677
Fares F, Gavish M (1986) Characterization of peripheral benzodiazepine receptors in human term placenta. Biochem Pharmacol 35: 227–230
Gale K (1980) Chronic blockade of dopamine receptors by antipsychotic drugs enhances GABA binding in substantia nigra. Nature 283: 569–570
Gavish M, Snyder SH (1980) Benzodiazepine-recognition sites on GABA receptors. Nature 278: 651–652
Gavish M, Awad M, Fares F (1985) Existence of sites for anions and divalent cations in the solubilized γ-aminodibutyric acid/benzodiazepine receptor comples. J Neurochem 45: 760–765
Gavish M, Okun F, Weizman A, Youdim MBH (1986a) Modulation of peripheral benzodiazepine binding sites following chronic estradiol treatment. Eur J Pharmacol 127: 147–151
Gavish M, Weizman A, Karp L, Tyano S, Tanne Z (1986b) Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics. Eur J Pharmacol 121: 275–279
Gavish M, Weizman A, Okun F, Youdim MBH (1986c) Modulatory effects of thyroxine treatment on central and peripheral benzodiazepine receptors in the rat. J Neurochem 47: 1106–1110
Gavish M, Weizman A, Youdim MBH, Okun F (1987) Regulation of central and peripheral benzodiazepine receptors in progesterone-treated rats. Brain Res 409: 386–390
Gehlert DR, Yamamura HI, Wamsley JK (1983) Autoradiographic localization of “peripheral” benzodiazepine binding sites in the rat brain and kidney using [3H]Ro 5-4864. Eur J Pharmacol 95: 329–330
Huffman RD, Ticku MK (1983) The effects of chronic haloperidol administration on GABA receptor binding. Pharmacol Biochem Behav 19: 199–204
Lindgren S (1987) Lack of effects of apomorphine, haloperidol, and clozapine on the synthesis and utilization of brain GABA. J Neural Transm 69: 47–57
Marangos JP, Patel J, Rosenberg RC (1982) Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol Pharmacol 22: 26–32
Mestre M, Bouetard G, Uzan A, Gueremy C, Renault C, Dubroeucq MC, Le Fur G (1985) PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and perfusion in the dog. Eur J Pharmacol 112: 257–260
Mestre M, Carriot T, Belin C, Uzan A, Renault C, Dubroeucq MC, Gueremy C, Le Fur G (1984) Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. Life Sci 35: 953–962
Mizoule J, Gauthier A, Uzan A, Renault C, Dubroeu M, Gueremy C, Le Fur G (1985) Opposite effects of two ligands for peripheral-type binding sites, PK 11195 and Ro 5- 4864, in a conflict situation in the rat. Life Sci 36: 1059–1068
Mohler H, Okada T (1977) Benzodiazepine receptor: demonstration in the central nervous system. Science 198: 849–851
Mohler H, Okada T, Heitz PH, Ulrich J (1978) Biochemical identification of the site of action of benzodiazepines in human brain. Life Sci 22: 985–996
Moingeon P, Dessaux JJ, Fellows R, Alberici GF, Bidart JM, Motte P, Bohuon C (1984) Benzodiazepine receptors on human blood platelets. Life Sci 35: 2003–2009
Pazo JH, Levi de Stein M, Jerusalinsky D, Novas ML, Rashovsky S, Tumilasci OR, Medina JH, Robertis E (1987) Selective increase of α1-adrenoceptors and muscarinic cholinergic receptors in rat cerebral cortex after chronic haloperidol. Brain Res 414: 405–408
Regan JW, Yamamura HI, Yamada S, Roeske WR (1981) High-affinity renal [3H]flunitrazepam binding: characterization, localization, and alterations in hypertension. Life Sci 28: 991–998
Rupniak NMJ, Prestwich SA, Horton RW, Jenner P, Marsden CD (1987) Alterations in cerebral glutamic acid decarboxylase and3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride, or clozapine. J Neural Transm 68: 113–125
Schoemaker H, Boles RG, Horst WD, Yamamura HI (1983) Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. J Pharmacol Exp Ther 225: 61–69
Sovner R, DiMascio A (1978) Extrapyramidal syndromes and other neurological side effects of psychotropic drugs. In: Lipton MA, DiMascio A, Killman KF (eds) Psychopharmacology—a generation of progress. Raven Press, New York, pp 1021–1032
Squires R, Braestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266: 732–734
Tallman JF, Thomas JW, Gallagher DW (1978) GABAergic modulation of benzodiazepinebinding site sensitivity. Nature 274: 383–385
Taniguchi T, Wang JKT, Spector S (1982) [3H]Diazepam binding sites on rat heart and kidney. Biochem Pharmacol 31: 589–590
Tanne Z, Weizman R, Karp L, Katz Y, Tyano S, Gavish M (1987) Lack of effect of 28 days of neuroleptic treatment on platelet benzodiazepine binding sites in schizophrenics. Neuropsychobiology 17: 121–123
Wang JKT, Taniguchi T, Spector S (1980) Properties of [3H]diazepam binding on rat blood platelets. Life Sci 27: 1881–1888
Weissman BA, Cott J, Jackson JA, Bolger GT, Weber KA, Horst WH, Paul SM, Skolnick P (1985) “Peripheral-type” binding sites for benzodiazepines in brain: relationship to the convulsant actions of Ro 5-4864. J Neurochem 44: 1494–1499
Weizman R, Tanne Z, Granek M, Karp L, Golomb M, Tyano S, Gavish M (1987) Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. Eur J Pharmacol 138: 289–292
Weizman R, Tanne Z, Karp L, Tyano S, Gavish M (1986) Peripheral-type benzodiazepine binding sites in platelets of schizophrenics with and without tardive dyskinesia. Life Sci 39: 549–557
Zharkovskii AM, Zharkovskaya TA (1985) Change in number of benzodiazepine receptors in different parts of the rat brain after neuroleptic withdrawal. Bull Exp Biol Med (Engl Transl Byull Eksp Biol Med) 98: 1390–1392
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gavish, M., Weizman, R., Becker, D. et al. Effect of chronic haloperidol treatment on peripheral benzodiazepine binding sites in cerebral cortex of rats. J. Neural Transmission 74, 109–116 (1988). https://doi.org/10.1007/BF01245144
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01245144